Literature DB >> 32914890

Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.

Weiqiang Li1, Mesude Bicak1, Daniel D Sjoberg2, Emily Vertosick2, Anders Dahlin3, Olle Melander3, David Ulmert4, Hans Lilja5,6, Robert J Klein1.   

Abstract

BACKGROUND: Testing for prostate-specific antigen (PSA) levels in blood are widely used and associated with prostate cancer risk and outcome. After puberty, PSA levels increase by age and multiple single nucleotide polymorphisms (SNPs) have been found to be associated with PSA levels. However, the relationship between the effects of SNPs and age on PSA remains unknown.
METHODS: To test for SNP × age interaction, we conducted a genome-wide association study using 2394 men without prostate cancer diagnosis from Malmö, Sweden as a discovery set and 2137 men from the eMERGE study (USA) for validation. Linear regression was used to identify significant interactions between SNP and age (p < 1 × 10-4 for discovery, p < .05 for validation).
RESULTS: The 15 SNPs from three different loci (8p11.22, 8p12, 3q25.31) are found to have age-specific effect on PSA levels. Expression quantitative trait loci (eQTLs) analysis shows that 12 SNPs from 3q25.31 locus affect the expression level of three genes: KCNAB1, SLC33A1, PLCH1.
CONCLUSIONS: Our results suggest that SNPs may have age-specific effect on PSA levels, which provides new direction to study genetic markers for PSA.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  GWAS; PSA; SNPs; eQTL; prostate cancer

Mesh:

Substances:

Year:  2020        PMID: 32914890      PMCID: PMC7606728          DOI: 10.1002/pros.24070

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  41 in total

1.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

2.  Expected population impacts of discontinued prostate-specific antigen screening.

Authors:  Roman Gulati; Alex Tsodikov; Ruth Etzioni; Rachel A Hunter-Merrill; John L Gore; Angela B Mariotto; Matthew R Cooperberg
Journal:  Cancer       Date:  2014-07-25       Impact factor: 6.860

3.  Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.

Authors:  Daniel D Sjoberg; Andrew J Vickers; Melissa Assel; Anders Dahlin; Bing Ying Poon; David Ulmert; Hans Lilja
Journal:  Eur Urol       Date:  2018-03-05       Impact factor: 20.096

4.  Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O-acetylated ganglioside: a putative acetyl-CoA transporter.

Authors:  A Kanamori; J Nakayama; M N Fukuda; W B Stallcup; K Sasaki; M Fukuda; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14

6.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

7.  4-aminopyridine decreases progesterone production by porcine granulosa cells.

Authors:  Yan Li; Suhasini Ganta; Fred B von Stein; Diane E Mason; Brianna M Mitchell; Lisa C Freeman
Journal:  Reprod Biol Endocrinol       Date:  2003-04-01       Impact factor: 5.211

8.  Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

Authors:  Julius Gudmundsson; Jon K Sigurdsson; Lilja Stefansdottir; Bjarni A Agnarsson; Helgi J Isaksson; Olafur A Stefansson; Sigurjon A Gudjonsson; Daniel F Gudbjartsson; Gisli Masson; Michael L Frigge; Simon N Stacey; Patrick Sulem; Gisli H Halldorsson; Vinicius Tragante; Hilma Holm; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; Thorvaldur Jonsson; Eirikur Jonsson; Rosa B Barkardottir; Rafn Hilmarsson; Folkert W Asselbergs; Gudmundur Geirsson; Unnur Thorsteinsdottir; Thorunn Rafnar; Gudmar Thorleifsson; Kari Stefansson
Journal:  Nat Commun       Date:  2018-11-08       Impact factor: 14.919

9.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Authors:  Alex Tsodikov; Roman Gulati; Eveline A M Heijnsdijk; Paul F Pinsky; Sue M Moss; Sheng Qiu; Tiago M de Carvalho; Jonas Hugosson; Christine D Berg; Anssi Auvinen; Gerald L Andriole; Monique J Roobol; E David Crawford; Vera Nelen; Maciej Kwiatkowski; Marco Zappa; Marcos Luján; Arnauld Villers; Eric J Feuer; Harry J de Koning; Angela B Mariotto; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391

10.  Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.

Authors:  Scooter Willis; Victor M Villalobos; Olivier Gevaert; Mark Abramovitz; Casey Williams; Branimir I Sikic; Brian Leyland-Jones
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

View more
  2 in total

1.  Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.

Authors:  Nishi Karunasinghe; Tsion Zewdu Minas; Bo-Ying Bao; Arier Lee; Alice Wang; Shuotun Zhu; Jonathan Masters; Megan Goudie; Shu-Pin Huang; Frank J Jenkins; Lynnette R Ferguson
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

2.  A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort.

Authors:  Xiaoling Lin; Yishuo Wu; Fang Liu; Rong Na; Da Huang; Danfeng Xu; Jian Gong; Yao Zhu; Bo Dai; Dingwei Ye; Hongjie Yu; Haowen Jiang; Zujun Fang; Jie Zheng; Qiang Ding
Journal:  Front Oncol       Date:  2021-10-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.